MEDIA ADVISORY, Sept. 25, 2006 (PRIMEZONE) --
What: Rajesh Shrotriya, Chairman and CEO of Spectrum Pharmaceuticals Inc. (SPPI) will preside over the closing bell to celebrate its 10-year listing anniversary on NASDAQ. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Tuesday September 26th, 2006 at 4:00 p.m. EDT Contacts: Virginia Amann 608-274-6046 firstname.lastname@example.org NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220
The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Spectrum Pharmaceuticals Inc. (SPPI):
Spectrum Pharmaceuticals opportunistically acquires and advances a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drug candidates with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at www.spectrumpharm.com.